Document Detail

Comparing alloimmunization in preterm infants after transfusion of fresh unmodified versus stored leukocyte-reduced red blood cells.
MedLine Citation:
PMID:  10363856     Owner:  NLM     Status:  MEDLINE    
PURPOSE: To compare the occurrence of red blood cell (RBC), platelet (PLT), and white blood cell (WBC) antibodies in preterm infants after transfusions.
METHODS: A randomized, blinded trial was conducted in which preterm infants were transfused either with stored RBCs, prepared by prestorage leukocyte reduction and transfused throughout 42 days of storage to limit donor exposure (n = 18), or with fresh RBCs prepared without leukocyte reduction and transfused within 7 days after collection from as many donors as needed to guarantee freshness (n = 17). Nontransfused preterm infants of comparable birth weight were control subjects (n = 11).
RESULTS: No RBC antibodies were detected in serial blood samples taken during the first 6 months of life. Similarly, no definite WBC antibodies were found, although weak reactivity was detected transiently in sera from two infants. Accordingly, RBC and WBC antibody production did not differ among groups. In all, 11% of the transfused the infants exhibited platelet antibodies: 14% of the infants given stored leukocyte-reduced RBCs and 7% of the infants given fresh nonleukocyte-reduced RBCs (difference not statistically significant).
CONCLUSIONS: Preterm infants rarely produce antibodies to blood cell antigens after RBC transfusions, regardless of whether the exposure is to fresh unmodified RBCs from several donors or to stored leukocyte-reduced RBCs from a limited number of donors. Therefore, efforts to limit donor exposures or to remove WBCs from blood components cannot be justified simply for purposes of preventing alloimmunization in neonates.
R G Strauss; D G Cordle; J Quijana; N E Goeken
Related Documents :
16607006 - Volume replacement in infants with dengue hemorrhagic fever/dengue shock syndrome.
15035456 - Haemopoietic growth factors for neonates: assessing risks and benefits.
10428996 - Comparison between two and five doses a week of recombinant human erythropoietin for an...
17130116 - Use of recombinant erythropoietin for the management of severe hemolytic disease of the...
11380916 - Correlation between neuroimaging and neurological outcome in periventricular leukomalac...
719196 - Lead concentration in the livers of canadians.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of pediatric hematology/oncology     Volume:  21     ISSN:  1077-4114     ISO Abbreviation:  J. Pediatr. Hematol. Oncol.     Publication Date:    1999 May-Jun
Date Detail:
Created Date:  1999-06-16     Completed Date:  1999-06-16     Revised Date:  2011-10-06    
Medline Journal Info:
Nlm Unique ID:  9505928     Medline TA:  J Pediatr Hematol Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  224-30     Citation Subset:  IM    
Department of Pathology, University of Iowa College of Medicine, Iowa City, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibody Formation
Blood Cells / immunology*
Blood Platelets / immunology
Blood Preservation*
Blood Transfusion*
Erythrocytes / immunology
Infant, Newborn
Infant, Premature / immunology*
Leukocytes / immunology
Grant Support
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Plasma homocysteine levels and folate status in children with sickle cell anemia.
Next Document:  Giant platelet disorders in African-American children misdiagnosed as idiopathic thrombocytopenic pu...